US Patent Issued to MEDSHINE DISCOVERY on Feb. 17 for "Quinazoline compound" (Chinese Inventors)

ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,552,787, issued on Feb. 17, was assigned to MEDSHINE DISCOVERY INC. (Jiangsu, China).

"Quinazoline compound" was invented by Lifang Wu (Shanghai), Fei Sun (Shanghai), Charles Z. Ding (Shanghai) and Shuhui Chen (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "A quinazoline compound and a pharmaceutically acceptable salt thereof, in particular a compound of formula (II) and a pharmaceutically acceptable salt thereof."

The patent was filed on July 23, 2021, under Application No. 18/005,347.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetaht...